| 1 |
Konieczny A, Ryba M, Wartacz J, et al.Podocytes in urine, a novel biomarker of preeclampsia ？[J]. Adv Clin Exp Med, 2013, 22(2): 145-149.
|
| 2 |
Hakim J, Senterman MK, Hakim AM.Preeclampsia is a biomarker for vascular disease in both mother and child: the need for a medical alert system[J]. Int J Pediatr, 2013: 953150.
|
| 3 |
Hahn S, Lapaire O, Than NG.Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary？[J]. Expert Rev Mol Diagn, 2015, 15(5): 617-629.
|
| 4 |
Ghosh SK, Raheja S, Tuli A, et al.Serum PLGF as a potential biomarker for predicting the onset of preeclampsia[J]. Arch Gynecol Obstet, 2012, 285(2): 417-422.
|
| 5 |
Ghosh SK, Raheja S, Tuli A, et al.Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy？[J]. Arch Gynecol Obstet, 2013, 287(5): 865-873.
|
| 6 |
Nikuei P, Malekzadeh K, Rajaei M, et al.The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia[J]. Iran J Reprod Med, 2015, 13(5): 251-262.
|
| 7 |
Stubert J, Ullmann S, Bolz M, et al.Prediction of preeclampsia and induced delivery at <34 weeks gestation by sFLT-1 and PlGF in patients with abnormal midtrimester uterine Doppler velocimetry: a prospective cohort analysis[J]. BMC Pregnancy Childbirth, 2014, 14: 292.
|
| 8 |
Odibo A, Zhong Y, Katherine R, et al.First-trimester Placental Protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of Preeclampsia [J]. Placenta, 2011, 32 (8): 598-602.
|
| 9 |
Foidart J, Munaut C, Chantraine F, et al.Maternal plasma soluble endoglin at 11 -13 weeks' gestation in preeclampsia[J]. Ultrasound Obstet Gynecol, 2010, 35 (6): 680-687.
|
| 10 |
Poon LC, Nicolaides KH.First-trimester maternal factors and biomarker screening for preeclampsia[J]. Prenat Diagn, 2014, 34(7): 618-627.
|
| 11 |
De Muro P, Capobianco G, Lepedda AJ, et al.Plasma PP13 and urinary GAGs/PGs as early markers of pre-eclampsia[J]. Arch Gynecol Obstet, 2016, 294(5): 959-965.
|
| 12 |
Chang Y, Chen X, Cui HY, et al.New predictive Model at 11＋0 to 13＋6 gestational weeks for early-onset preeclampsia with fetal growth restriction[J]. Reprod Sci, 2017, 24(5): 783-789.
|
| 13 |
颜建英，林元，张东妹，等．妊娠中、晚期血清瘦素、β-hCG及ADAM12水平的变化及其与子痫前期发生的关系[J]．国际妇产科学杂志国际妇产科学杂志，2013，40(6)：517-520.
|
| 14 |
Kasimis C, Evangelinakis N, Rotas M, et al.Predictive value of biochemical marker ADAM-12 at first trimester of pregnancy for hypertension and intrauterine growth restriction[J]. Clin Exp Obstet Gynecol, 2016, 43(1): 43-47.
|
| 15 |
Hansson SR, Nääv Å, Erlandsson L. Oxidative stress in preeclampsia and the role of free fetal hemoglobin[J]. Front Physiol, 2015, 5: 516.
|
| 16 |
Olsson MG, Centlow M, Rutardóttir S, et al.Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger alpha(1)-microglobulin in preeclampsia[J]. Free Radic Biol Med, 2010, 48(2): 284-291.
|
| 17 |
Anderson UD, Gram M, Ranstam J, et al.Fetal hemoglobin, α1-microglobulin and hemopexin are potential predictive first trimester biomarkers for preeclampsia[J]. Pregnancy Hypertens, 2016, 6(2): 103-109.
|
| 18 |
Wester-Rosenlöf L, Casslén V, Axelsson J, et al. A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia[J]. PLoS One, 2014, 9(1): e86353.
|
| 19 |
Siddiqui MF, Nandi P, Girish GV, et al.Decorin over-expression by decidual cells in preeclampsia: a potential blood biomarker[J]. Am J Obstet Gynecol, 2016, 215(3): 361.
|
| 20 |
Santillan MK, Santillan DA, Scroggins SM, et al.Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model[J]. Hypertension, 2014, 64(4): 852-859.
|
| 21 |
Taché V, Baer RJ, Currier RJ, et al.Population-based biomarker screening and the development of severe preeclampsia in California[J]. Am J Obstet Gynecol, 2014, 211(4): 377.
|
| 22 |
Wang Q, Liu C, Zhang Z. Transthyretin and Normal Human Pregnancy: Mini Review[J]. Crit Rev Eukaryot Gene Expr, 2016, 26(3): 273-277.
|
| 23 |
Zhu L, Chen Y, Liu C, et al.Transthyretin as a novel candidate biomarker for preeclampsia[J]. Exp Ther Med, 2014, 7(5): 1332-1336.
|
| 24 |
Anderson CM, Ralph JL, Wright ML, et al.DNA methylation as a biomarker for preeclampsia[J]. Biol Res Nurs, 2014, 16(4): 409-420.
|
| 25 |
Lapaire O, Grill S, Lalevee S, et al.Microarray screening for novel preeclampsia biomarker candidates[J]. Fetal Diagn Ther, 2012, 31(3): 147-153.
|
| 26 |
Carty DM, Siwy J, Brennand JE, et al.Urinary proteomics for prediction of preeclampsia[J]. Hypertension, 2011, 57(3): 561-569.
|
| 27 |
Krauspenhar B, Sontag F, Ronchi FA, et al.Angiotensin Converting Enzyme 90 kDa isoform: Biomarker for diagnosis of preeclampsia？[J]. Med Hypotheses, 2014, 83(5): 526-529.
|
| 28 |
Konieczny A, Ryba M, Wartacz J, et al.Podocytes in urine, a novel biomarker of preeclampsia？[J]. Adv Clin Exp Med, 2013, 22(2): 145-149.
|
| 29 |
Norwitz ER, Tsen LC, Park JS, et al.Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsia[J]. Am J Obstet Gynecol, 2005, 193(3 Pt 2): 957-964.
|
| 30 |
Mary S, Patil GV, Kulkarni AV, et al.Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biomarker discovery[J]. Proteomics Clin Appl, 2012, 6(1-2): 79-90.
|
| 31 |
Acestor N, Goett J, Lee A, et al.Towards biomarker-based tests that can facilitate decisions about prevention and management of preeclampsia in low-resource settings[J]. Clin Chem Lab Med, 2016, 54(1): 17-27.
|